ECOG Protocols Active as of 05/16/08

Click on the protocol number to view the NCI's PDQ description of the protocol.

MELANOMA COMMITTEE


ProtocolTitle
E1602 A Randomized Phase II Trial of Multi-epitope Vaccination with Melanoma Peptides for Cytotoxic T-Cells and Helper T-Cells for Patients with Metastatic Melanoma
Activation Date: 21-mar-2005
ECOG Participants(requires Adobe Acrobat)
E1697 Phase III Randomized Study of Four Weeks High Dose IFN-A2B in Stage T2B NO, T3A-B NO, T4A-B NO, and T1-4, N1A, 2A, 3 (microscopic) Melanoma
Activation Date: 22-dec-1998
E2602 A Phase II Study of Low Dose Peginterferon Alfa-2b in Patients with Metastatic Melanoma Over-Expressing Basic Fibroblast Growth Factor.
Activation Date: 05-sep-2003
ECOG Participants(requires Adobe Acrobat)

Back

How to contact ECOG

All contents copyright © 1998 Eastern Cooperative Oncology Group.
All rights reserved.
Revised: 05/16/08